Tag Archives: Rachel Haurwitz

New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute

An epic legal battle over CRISPR-Cas9 genome editing ended last year. But another one, smaller in scope and involving two long-time CRISPR allies, has quietly begun. Last October, Intellia Therapeutics (NASDAQ: NTLA) began an arbitration proceeding against Caribou Biosciences, alleging in a recent regulatory filing that its longstanding partner had broken the terms of a […]

Posted in Boston blog main, Boston top stories, National blog main, National top stories, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute

Roundup: Caringo, Aging 2.0, Disruptors Agenda, Cloud Sites, Trey Bowles

Let’s catch up with the latest innovation news from Xconomy Texas. —Caringo, an Austin startup that makes software that can enable customers to manage, organize, and search extremely large amounts of data, has raised $8.8 million in a Series B round of funding, bring its total investment raised to $33 million. Investors include New Science […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Roundup: Caringo, Aging 2.0, Disruptors Agenda, Cloud Sites, Trey Bowles

Caribou CEO Touts Incubator’s Role Translating Science into Startup

San Antonio — [Corrected 10/3/16, 5 p.m.] For a researcher trying to turn their science into a business, sometimes the big issues—such as perfecting an intricate scientific process like gene editing—feels like a less daunting task than what might seem to be smaller stuff, like finding an attorney to help incorporate a business, says Rachel Haurwitz, the […]

Posted in Boston blog main, National blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Caribou CEO Touts Incubator’s Role Translating Science into Startup

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to home, Cleveland (pictured) celebrated LeBron James & the Cavaliers’ historic comeback that brought the city its first sports title in over 50 years. […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Detroit blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

Caribou Bio’s New CRISPR Patent Isn’t About Gene Editing

If you ask people who don’t follow biotech too closely what they know about CRISPR, you might get two answers: genetic editing and a big patent fight. But a new CRISPR patent highlights a lower-profile potential use for the biotechnology: genetic detection and analysis. The U.S. Patent and Trademark Office granted the patent Tuesday to […]

Posted in Boston blog main, Boston top stories, National blog main, National top stories, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off on Caribou Bio’s New CRISPR Patent Isn’t About Gene Editing